Soren Tulstrup

Soren Tulstrup is an experienced executive in the life sciences sector, currently serving as Board Director at MonTa Biosciences and Advisory Board Member at Appnovation and GLG Institute. As President & CEO of Hansa Biopharma until May 2025, Soren has also held advisory roles at Santhera Pharmaceuticals and previously served as Senior Advisor to the Chairmanship of a FTSE 250 Pharma Company and various private equity firms. Soren's career includes leadership positions at Vifor Pharma as CEO, Shire Pharmaceuticals as Senior Vice President, and Santaris Pharma A/S as President & CEO. Soren spent over a decade at Merck & Co., Inc., where roles included Vice President of Global Human Health. Educational credentials include a Master of Management from Northwestern University's Kellogg School of Management, participation in the International Directors Programme at INSEAD, and degrees in Economics & Business Administration from Copenhagen Business School.